Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept synovial biomarker study in rheumatoid arthritis
NL-OMON22398Recruiting
- Sponsor
- AMC Health
- Start
- Nov 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of abatacept in rheumatoid arthritis (RA), sponsored by AMC Health. Primary endpoint: Change in synovial inflammation. Started Nov 2010; status: recruiting.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON22398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22398.